MALVERN, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led
biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address
significant unmet needs in medical and aesthetic dermatology, today announced that members of its management team will present and
host investor meetings at the following upcoming investor events:
- Management will host investor meetings during Citi’s 12th Annual Biotech Conference in Boston, MA on Wednesday, September 6,
2017.
- Dr. Neal Walker, President and Chief Executive Officer, will present at the Morgan Stanley 15th Annual Global Healthcare
Conference in New York, NY on Tuesday, September 12, 2017 at 5:15 PM EDT.
- Dr. Walker will also present at the Cantor Fitzgerald Global Healthcare Conference in New York, NY on Tuesday, September 26,
2017 at 9:10 AM EDT.
A live webcast of the Morgan Stanley 15th Annual Global Healthcare Conference and the Cantor Fitzgerald Global Healthcare
Conference presentations may be accessed through the Company's web site, www.aclaristx.com, on the 'Events and Presentations' section. An archived version of the
presentation will be available for 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing
innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is
focused on large, underserved market segments with no FDA-approved medications or where treatment gaps exist. Aclaris is
based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.
Contact: Aclaris Contact Michael Tung, M.D. Vice President / Investor Relations 484-329-2140 mtung@aclaristx.com Media Contact Mariann Caprino TogoRun 917-242-1087 M.Caprino@togorun.com
